Bridgeway Capital Management’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-17,950
| Closed | -$245K | – | 1376 |
|
|
2023
Q3 | $245K | Hold |
17,950
| – | – | 0.01% | 1052 |
|
|
2023
Q2 | $366K | Hold |
17,950
| – | – | 0.01% | 996 |
|
|
2023
Q1 | $393K | Sell |
17,950
-6,975
| -28% | -$153K | 0.01% | 942 |
|
|
2022
Q4 | $408K | Sell |
24,925
-6,700
| -21% | -$110K | 0.01% | 931 |
|
|
2022
Q3 | $288K | Hold |
31,625
| – | – | 0.01% | 1053 |
|
|
2022
Q2 | $154K | Sell |
31,625
-3,875
| -11% | -$18.9K | ﹤0.01% | 1145 |
|
|
2022
Q1 | $267K | Buy |
35,500
+4,200
| +13% | +$31.6K | 0.01% | 1110 |
|
|
2021
Q4 | $282K | Hold |
31,300
| – | – | 0.01% | 1111 |
|
|
2021
Q3 | $511K | Buy |
+31,300
| New | +$511K | 0.01% | 1024 |
|